Abstract
Vaccine hesitancy is complex, multi-causative phenomenon that undermines public health efforts to contain the spread of infectious diseases. Improving our understanding of the drivers of vaccine hesitancy might improve our capacity to address it. We used the results of the May 2021 ASPE’s survey on COVID-19 vaccine-hesitancy which estimated the proportion of adults that felt hesitant of unsure towards taking the COVID-19 vaccine when it becomes available at the county-level. We developed a prediction model to identify the most important predictors of vaccine-hesitancy. The potential predictors included demographic characteristics, the CDC’s social vulnerability index, and the Republican Party’s voting share in the 2020 presidential election as a proxy of political affiliation, both at the county-level. The most important drivers of hesitancy included low educational attainment, proportion of Black/African American population, and political affiliation. These results deepen our understanding of the phenomenon and could help design more targeted interventions to reduce hesitancy in specific sub-groups of the population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
2021 U.S. Census' Bureau Household Pulse Survey (HPS) to measure levels of hesitancy towards the COVID-19 vaccine. American Community Survey 5-years to obtain county-level demographic information
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
